Mimetas Operations US, CO.

Gaithersburg, MD

UEI
M9RJXA9M7L68
CAGE
8NJK1
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
704 Quince Orchard Rd #260, Gaithersburg, MD 20878, USA
Website
mimetas.com
Founded
2011
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 -$23,300
FY2025 $0
FY2024 -$33,264

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Products and Services

The government contractor primarily provides microfluidic 3D cell culture plates, specifically the Organoplate Graft (part number 6401-400-B). These products are used in various scientific research projects, including those related to SARS-CoV-2 and COVID-19. Over time, the contractor's product offerings have remained consistent, focusing on the Organoplate Graft.

Customers

The contractor's primary customer is the Department of Health and Human Services (HHS), specifically the National Institutes of Health (NIH). The NIH has consistently awarded contracts to this contractor over time. The contractor's products have been used in various projects, including those related to COVID-19 and SARS-CoV-2.

Vehicles

The contract vehicle used for these awards is the Purchase Order. This has remained consistent throughout the contract award history.

Summary

The government contractor has a consistent history of providing Organoplate Grafts to the NIH for various research projects. The NIH has consistently been the contractor's primary customer, and the Purchase Order has been the consistent contract vehicle. The contractor's products have been used in critical research projects, including those related to COVID-19 and SARS-CoV-2.

Data

The analysis is based on six contracts awarded between 08/26/20 and 08/11/22.

Quick answers

Is Mimetas Operations US, CO. registered in SAM.gov?

Yes. Mimetas Operations US, CO.'s SAM.gov registration is active through April 22, 2027.

What is Mimetas Operations US, CO.'s CAGE code?

Mimetas Operations US, CO.'s CAGE code is 8NJK1, and its Unique Entity ID (UEI) is M9RJXA9M7L68.

What is Mimetas Operations US, CO.'s most recent federal award?

Mimetas Operations US, CO.'s most recent federal contract award is Mimetas organoplate graft 3 lane 64 chip plate microfluidic 3D cell culture plate 6401-400-B (75N95022P00442), from National Institute on Drug Abuse (NIH), on August 11, 2022.

On GovTribe

See Mimetas Operations US, CO.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe